Therapeutics Information for Providers

This page is for health care providers. Looking for Test to Treat sites near you?

Providers: Just want to use the site finder? Go to Treatment Finder for Providers and People with Prescriptions

Latest Updates

Aug. 5, 2022

July 6, 2022

  • FDA revises EUA for Paxlovid: On July 6 2022, the U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. Read the full news release. View the revised Paxlovid Fact Sheet for Healthcare Providers.

View All Updates by Date

Product Summaries and Allocation Requests

Providers who want to receive allocations of new therapeutic products as they are released will need to register through NCDHHS and the federal portal following the instructions provided by NCDHHS.

Paxlovid Clinical Resources

More Provider Resources

Provider Office Hours

Join the NCDHHS COVID-19 Therapeutics Team for our monthly office hours (typically the second Friday of the month, at 12 p.m. ET) to discuss updates to and address questions related to all COVID-19 Therapeutics.

  • Join on Teams
  • Or call in (audio only): +1 984-204-1487 (Conference ID: 450 669 154#)

More Resources

Need Help?

Submit inquiries, issues and feedback to the Therapeutics Mailbox (

All Updates by Date

Have questions? We're here to help.
Submit inquiries, issues and feedback to the Therapeutics Mailbox (